FDA
- Status: approved
autologous bone marrow concentrate (autologous bone marrow concentrate) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Istituto Ortopedico Rizzoli is the originator. The local marketing authorisation holder may differ — check the official source linked above.